An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy

Canadian Journal of Neurological Sciences

Volumn 41, Issue 4, 2014, Pages 508-511

  Jouan, L ^a,b   Rocheford, D ^a,b   Szuto, A ^a,b   Carney, E ^d   David, K ^d,e   Dion, P A ^a,b,c   Rouleau, G A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d NEW YORK METHODIST HOSPITAL   (United States)

^e METROPOLITAN HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE;

ADULT; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; MALE; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; GENETICS; MIDDLE AGED; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; PEDIGREE; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT;

ALANINE; FEMALE; HUMANS; MIDDLE AGED; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; PEDIGREE; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84901806193     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100018588     Document Type: Article

References (12)

1. Abu-Baker A, Rouleau GA. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim Biophys Acta. 2007;1772(2):173-85. (Pubitemid 46138035)
2. Robinson DO, Hammans SR, Read SP, Sillibourne J. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism. Hum Genet. 2005;116(4):267-71. (Pubitemid 40277238)
3. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18(2):164-7. (Pubitemid 28082465)
4. Hebbar S, Webberley MJ, Lunt P, Robinson DO. Siblings with recessive oculopharyngeal muscular dystrophy. Neuromuscul Disord. 2007;17(3):254-7. (Pubitemid 46413754)
5. Hill ME, Creed GA, McMullan TF, et al. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a UK population. Brain. 2001;124(Pt 3):522-6. (Pubitemid 32221319)
6. Semmler A, Kress W, Vielhaber S, Schroder R, Kornblum C. Variability of the recessive oculopharyngeal muscular dystrophy phenotype. Muscle Nerve. 2007;35(5):681-4. (Pubitemid 46676860)
7. Tondo M, Gamez J, Gutierrez-Rivas E, Medel-Jimenez R, Martorell L. Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy. J Neurol. 2012;259(8):1546-52.
8. Becher MW, Morrison L, Davis LE, et al. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA. 2001; 286(19):2437-40. (Pubitemid 33098162)
9. Blumen SC, Brais B, Korczyn AD, et al. Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol. 1999;46(1):115-18. (Pubitemid 29314390)
10. Blumen SC, Sadeh M, Korczyn AD, et al. Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews. Neurology. 1996;46(5):1324-8. (Pubitemid 26164647)
11. Blumen SC, Bouchard JP, Brais B, et al. Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology. 2009;73(8):596-601.
12. Dubbioso R, Moretta P, Manganelli F, et al. Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy. J Neurol. 2012;259(5):833-7.